Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India
Hematology, 05/28/09
Kar R et al. - Taking the MFI range of 5341·1-10 557·5 for HS, eight cases of suspected HS/undiagnosed hemolytic anemia with a negative or equivocal incubated OFT were diagnosed as HS. An increase in HbF level was seen in 10 cases ranging from 2·1 to 17·7% with a mean of 5·66%, three of these had associated beta thalassaemia trait. Twelve patients (17%) underwent splenectomy and 91% of them did not require any BT post-splenectomy. Among the patients treated conservatively 49% had persisting pallor and 16·3% had transfusion requirement.
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases
World Journal of Gastroenterology, 10/12/09
Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09
Sickle cell disease and stroke
Blood, 10/13/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


